Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.96% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Communication Services | 11.56% |
| 4 | Technology | 11.12% |
| 5 | Energy | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMND
351
DELISTED
DIAMOND FOODS, INC.
DMND
| $43.8M | 0.04% |
1,554,732
+626,810
| +68% | +$19.2M |
|
|
GLDD
352
DELISTED
Great Lakes Dredge & Dock
GLDD
| $43M | 0.04% |
5,378,234
+34,527
| +0.6% | +$281K |
|
353
CALL
Vertex Pharmaceuticals
VRTX
$122B
| $42.6M | 0.04% |
+450,000
| New | +$31.6M |
|
354
Acadia Healthcare
ACHC
$2.99B
| $42.4M | 0.04% |
931,426
-71,704
| -7% | -$3.15M |
|
|
NVDQ
355
DELISTED
Novadaq Technologies Inc.
NVDQ
| $42.2M | 0.04% |
2,559,866
+18,405
| +0.7% | +$303K |
|
356
Freeport-McMoran
FCX
$90.2B
| $42.1M | 0.04% |
1,154,019
-2,540
| -0.2% | -$86.9K |
|
357
Zions Bancorporation
ZION
$10B
| $39.8M | 0.04% |
1,350,026
+507,838
| +60% | +$14.9M |
|
358
Dorman Products
DORM
$4.08B
| $39.5M | 0.04% |
800,016
+143,035
| +22% | +$7.8M |
|
|
BRCD
359
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $39.1M | 0.04% |
4,245,742
+600,219
| +16% | +$5.53M |
|
|
DFRG
360
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $38.9M | 0.04% |
1,410,627
+479,853
| +52% | +$12.8M |
|
361
Benchmark Electronics
BHE
$2.86B
| $38.7M | 0.04% |
1,520,182
+779,813
| +105% | +$18.3M |
|
|
DRC
362
DELISTED
DRESSER-RAND GROUP INC
DRC
| $38.1M | 0.04% |
598,292
-33,872
| -5% | -$2.07M |
|
|
RVNC
363
DELISTED
Revance Therapeutics, Inc.
RVNC
| $38.1M | 0.04% |
1,121,134
+946,162
| +541% | +$29.6M |
|
|
PETX
364
DELISTED
Aratana Therapeutics, Inc.
PETX
| $38M | 0.04% |
2,437,004
+529,147
| +28% | +$7.5M |
|
365
Wheaton Precious Metals
WPM
$50.9B
| $37.9M | 0.03% |
1,444,324
-2,608
| -0.2% | -$58.4K |
|
366
Travere Therapeutics
TVTX
$5.27B
| $37.6M | 0.03% |
3,201,470
+1,231,651
| +63% | +$16.7M |
|
|
HOLX
367
DELISTED
Hologic
HOLX
| $37.3M | 0.03% |
1,472,803
-307,144
| -17% | -$7.18M |
|
|
PINC
368
DELISTED
Premier
PINC
| $36.4M | 0.03% |
1,253,519
-23,742
| -2% | -$712K |
|
369
FedEx
FDX
$73.5B
| $36M | 0.03% |
237,813
+44,601
| +23% | +$6.23M |
|
|
CMCSK
370
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $35.9M | 0.03% |
672,988
+110,741
| +20% | +$5.91M |
|
|
MACK
371
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $35.3M | 0.03% |
614,857
-127,313
| -17% | -$6.46M |
|
|
CEB
372
DELISTED
CEB Inc.
CEB
| $35M | 0.03% |
512,619
-164,560
| -24% | -$11.3M |
|
|
QLIK
373
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $34.9M | 0.03% |
1,540,799
-34,468
| -2% | -$790K |
|
374
Vipshop
VIPS
$7.08B
| $34.7M | 0.03% |
1,850,300
+208,960
| +13% | +$3.35M |
|
|
TMH
375
DELISTED
Team Health Holdings Inc
TMH
| $34.7M | 0.03% |
695,156
-163,854
| -19% | -$7.92M |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.